Editorial Board
Niansong Qian
Department of Hepatobiliary Surgery, PLA General Hospital · China
Editorial leadership for Journal of Fetal Surgery ISSN 2997-2086
Research interests
- Oncology
Biography
Education:
- 2011 M.D. Ph.D.,, The Fouth Military medical, University of China.
Postdoctoral study:
- 2011-2013 Research Fellow, Department of Hepatobiliary surgery, Chinese Medical College of People’s Liberation Army.
Hospital Appointments:
- 2011-now attending doctor, Chinese People’s Liberation Army General Hospital.
Academic Appointments:
- 2009-2011 Academic Visitor, Kyoto medical Hospital, Kyoto University.
Academic Board:
- 2011 - Executive Board member, Chinese Society of Medical Oncology.
Awards:
- 2012 - First Class Hainan province Science and Technology Progress Award.
- 2011 - Beijing Nova promising talent.
Selected publications
- The Role of Serum CEA and CA19-9 in Efficacy Evaluations and Progression-Free Survival Predictions for Patients Treated with Cetuximab Combined with FOLFOX4 or FOLFIRI as a First-Line Treatment for Advanced Colorectal Cancer 2019 cited 25×
- Hyperprogressive Disease Caused by PD-1 Inhibitors for the Treatment of Pan-Cancer 2021 cited 19×
- Analysis of a Systemic Inflammatory Biomarker in Advanced Bile Tract Carcinoma Treated with Anti-PD-1 Therapy: Prognostic and Predictive Significance of Lung Immune Prognostic Index Score 2022 cited 7×
- Changes in the neutrophil-to-lymphocyte ratio (NLR) as predictive values for metastatic gastric cancer patients with PD-1 inhibitors 2024 cited 3×
- Prospect of immunotherapy alone in patients with advanced NSCLC with high btmb: a review and a meta-analysis 2023 cited 1×
- Association of Antibiotic Used During Surgery With the Outcome in Stage I-III Gastric Cancer Recent 2025
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JFS for your work?
This journal is guided by Niansong Qian (Department of Hepatobiliary Surgery, PLA General Hospital) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.